Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

SELL
$98.98 - $115.74 $2.14 Million - $2.51 Million
-21,662 Reduced 28.9%
53,301 $6.17 Million
Q2 2023

Aug 04, 2023

BUY
$96.34 - $112.38 $4.28 Million - $5 Million
44,457 Added 145.73%
74,963 $7.71 Million
Q1 2023

Apr 27, 2023

SELL
$107.32 - $113.5 $889,360 - $940,574
-8,287 Reduced 21.36%
30,506 $3.33 Million
Q4 2022

Feb 02, 2023

BUY
$62.39 - $113.8 $2.42 Million - $4.41 Million
38,793 New
38,793 $4.41 Million
Q2 2022

Aug 03, 2022

BUY
$79.4 - $116.36 $2.88 Million - $4.22 Million
36,280 New
36,280 $2.89 Million
Q1 2022

May 02, 2022

SELL
$86.42 - $109.81 $1.9 Million - $2.41 Million
-21,935 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$98.56 - $119.91 $312,040 - $379,635
3,166 Added 16.87%
21,935 $2.36 Million
Q3 2021

Oct 28, 2021

SELL
$91.91 - $110.37 $85,476 - $102,644
-930 Reduced 4.72%
18,769 $1.81 Million
Q2 2021

Aug 12, 2021

SELL
$86.24 - $95.92 $2.5 Million - $2.78 Million
-28,983 Reduced 59.54%
19,699 $1.84 Million
Q1 2021

Apr 26, 2021

SELL
$71.83 - $95.48 $624,490 - $830,103
-8,694 Reduced 15.15%
48,682 $0
Q4 2020

Feb 02, 2021

BUY
$67.0 - $84.39 $2.81 Million - $3.54 Million
41,925 Added 271.34%
57,376 $4.2 Million
Q3 2020

Oct 14, 2020

BUY
$55.23 - $79.93 $853,358 - $1.23 Million
15,451 New
15,451 $1.2 Million
Q4 2019

Feb 05, 2020

SELL
$25.43 - $36.67 $53,581 - $77,263
-2,107 Closed
0 $0
Q3 2019

Oct 15, 2019

SELL
$23.0 - $27.97 $52,049 - $63,296
-2,263 Reduced 51.78%
2,107 $57,000
Q2 2019

Jul 26, 2019

BUY
$22.81 - $28.48 $99,679 - $124,457
4,370 New
4,370 $105,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.